Translational Genomics Core (TGC)
Director
Jovanny Zabaleta, PhD
504-210 2979
jzabal@lsuhsc.edu
Mission
The Cancer Center Translational Genomics Core (TGC) provides LSU-LCMC Health Cancer Center investigators with the latest genomic technologies, state-of-the-art facilities and expert guidance to characterize the genomes, transcriptomes and epigenomes of cancers and their microenvironment. The Core supports projects from isolation, qualification and quantification of nucleic acids through library preparation, sequencing and analysis, and trains faculty, students and staff at every step. By delivering high-quality genomic data, TGC helps members uncover the molecular drivers of cancer, identify biomarkers and inherited cancer risk, and advance precision oncology.
Description
TGC provides the full range of genomic analysis for cancer research. Bulk sequencing services include RNA-seq, whole-genome and exome sequencing, ChIP-seq, ATAC-seq, microRNA-seq, Methyl-seq and 16S and shotgun metagenomic sequencing for microbiome studies. Focused panels such as TST500 and BRCA profile clinically relevant cancer genes, while genotyping arrays support GWAS of cancer risk and array-based methylation studies map the tumor epigenome.
Beyond bulk profiling, TGC offers single-cell sequencing on the 10x Genomics Chromium X and spatial transcriptomics, from exploratory region-of-interest profiling on the NanoString GeoMx to single-cell resolution on the Vizgen MERSCOPE. These platforms let investigators resolve tumor heterogeneity, clonal populations and the composition and spatial organization of the tumor immune microenvironment in intact tissue. Sanger sequencing, real-time and digital PCR, and NanoString nCounter panels support validation and targeted follow-up.
All projects begin with rigorous quality assessment of nucleic acids on the Agilent BioAnalyzer and Qubit. TGC uses Partek Flow to provide a rapid view of differentially expressed genes, variants and differentially abundant microbial species, and to generate heatmaps, volcano plots, PCA, t-SNE and UMAP plots and other publication-quality figures. More advanced and integrative analyses are available in collaboration with the Cancer Center Bioinformatics Core.
Location
Louisiana Cancer Research Center (LCRC), 1700 Tulane Ave., 9th Floor, Rooms 929, 930 and 931, New Orleans, LA 70112
Sequencing and Arrays
- Illumina NextSeq 2000
- Illumina MiSeq
- Illumina iScan
- Applied Biosystems 3500xL Genetic Analyzer
- Applied Biosystems SeqStudio Genetic Analyzer
Single-Cell and Spatial Genomics
- 10x Genomics Chromium X single-cell preparation station
- NanoString GeoMx Digital Spatial Profiler
- Vizgen MERSCOPE
- NanoString nCounter SPRINT
PCR
- Applied Biosystems QuantStudio 12K Flex Real-Time PCR System
- QIAGEN QIAcuity One Digital PCR System
- Bio-Rad C1000 Touch Thermal Cycler
Sample Preparation and Quality Control
- QIAGEN EZ2 Connect automated nucleic acid extraction instrument
- Covaris M220 Focused-ultrasonicator
- Sage Science PippinHT high-throughput size selection for NGS
- Agilent 2100 BioAnalyzer
- Thermo Fisher Qubit fluorometer
A consultation with TGC personnel is highly recommended, because the cost of a sequencing project depends on several factors, including but not limited to:
- RNA-seq: fees are based on RNA quality and the aims of the project. RNA quality is assessed on the Agilent BioAnalyzer and quantity on the Qubit; together these determine the type of library preparation required.
- DNA-seq (exome, whole-genome): cost per sample is determined by the sequencing depth required by the investigator.
- ChIP-seq and ATAC-seq: the investigator provides the purified DNA.
Other Services
- Microbial sequencing (16S, shotgun metagenomics)
- microRNA-seq
- Methyl-seq and array-based methylation studies
- Single-cell sequencing
- Focused cancer panel sequencing (TST500, BRCA, etc.)
- Spatial transcriptomics (exploratory with the GeoMx; single-cell level with the Vizgen MERSCOPE)
- GWAS
- DNA fragmentation
- Nucleic acid quality assessment
- Sanger sequencing
- NanoString panels
Fee schedule (internal and external rates): TBD
TGC encourages all investigators to contact Core personnel (initially by email, then in person or via Zoom) to discuss the project, its goals and the expected outcome. This allows the Core to estimate the reagents required and to recommend the approach that will give the best possible results for the project.
- Bulk next-generation sequencing of cancer genomes, transcriptomes and epigenomes (RNA-seq, WGS, exome, ChIP-seq, ATAC-seq)
- Targeted cancer gene panel sequencing (TST500, BRCA)
- Single-cell sequencing (10x Genomics Chromium X)
- Spatial transcriptomics of the tumor microenvironment (NanoString GeoMx, Vizgen MERSCOPE)
- DNA methylation and microRNA profiling
- Sanger sequencing, real-time and digital PCR, and NanoString nCounter panels